US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Obesity: market research reports

Weight loss and diet management is a challenge for millions of people around the world. Globally, more than 1 billion people are above an ideal weight. In addition to the negative social effects being overweight has on an individual, the health effects can be deadly. The affects weight has on life-threatening or life-altering disease are devastating.
Diseases such as diabetes, heart disease, and cancer all have links to being overweight or obese.

Increasing education efforts, accessible weight management plans and foods, and a growing desire to be physically desirable have fueled this market in more recent years. More than 100 million people in the United States are actively involved in a weight loss or weight management plan at any one time throughout the year. This suggests a demand for products and services which will continue for years to come.

The definitions or measurement characteristics for overweight and obesity have varied over time. The varied definitions affect prevalence statistics and make it difficult to compare data from different studies. The prevalence of overweight and obesity is commonly assessed by using body mass index (BMI). A BMI over 25 kg/m2 is defined as overweight, and a BMI of over 30 kg/m2 as obese. These markers provide the common benchmarks for assessment, but the risks of disease in all populations can increase progressively from lower BMI levels.

According to the World Health Organization, adult mean BMI levels of 22-23 kg.m2 are found in Africa and Asia, while levels of 25-27 kg.m2 are prevalent across North America, Europe, and in some Latin American, North African and Pacific Island countries. BMI increases among middle-aged elderly people, who are at the greatest risk of health complications. In countries undergoing nutrition transition, overnutrition often coexists with undernutrition. People with a BMI below 18.5 kg/m2 tend to be underweight.

RSS Feeds

Obesity market research reports and industry analysis

< prev 1    3  4  5  6  
India Bariatric Surgery Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... market segments - Gastric Bypass Procedures, Sleeve Gastrectomy Procedures and Gastric Banding Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the ...  |  read more...
USD 175
Japan Bariatric Surgery Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... market segments - Gastric Bypass Procedures, Sleeve Gastrectomy Procedures and Gastric Banding Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the ...  |  read more...
USD 175
South Korea Bariatric Surgery Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... procedure volumes within market segments - Gastric Bypass Procedures, Sleeve Gastrectomy Procedures and Gastric Banding Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate ...  |  read more...
USD 175
United States Bariatric Surgery Devices Market Outlook to 2020
7/1/2014 | published by: GlobalData
... The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Bariatric Stapling Devices, Gastric Bands and Gastric Balloons. The report also provides company ...  |  read more...
USD 2,500
China Bariatric Surgery Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... market segments - Gastric Bypass Procedures, Sleeve Gastrectomy Procedures and Gastric Banding Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the ...  |  read more...
USD 175
Russia Bariatric Surgery Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... market segments - Gastric Bypass Procedures, Sleeve Gastrectomy Procedures and Gastric Banding Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the ...  |  read more...
USD 175
Health and Wellness in Australia
5/22/2014 | published by: Euromonitor International
... of 6%. Australian consumers displayed a preference for packaged food and beverages with health and wellness properties and were willing to pay a premium for such products. In response, manufacturers emphasised and expanded their health ...  |  read more...
USD 1,900
Abdominal Obesity Global Clinical Trials Review, H1, 2014
5/5/2014 | published by: GlobalData
... information and data relating to the clinical trials on Abdominal Obesity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Anti-Obesity Drugs
5/1/2014 | published by: Global Industry Analysts
... estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are ...  |  read more...
USD 4,950
Update: Obesity Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing ...  |  read more...
USD 590
Obesity Partnering 2009-2014
4/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Obesity Partnering 2009-2014 provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 995
Obesity - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... Obesity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Worksite Weight Loss Programs: A Market Analysis
12/1/2013 | published by: Marketdata Enterprises Inc.
... a flat overall weight loss market, as employers get more serious about reducing health insurance claims related to obesity. The Affordable Care Act is likely to spur more demand for these programs as well. Obesity-related ...  |  read more...
USD 2,197
Bariatric Surgery: Global Markets for Services and Devices
11/1/2013 | published by: BCC Research
... almost $1.9 billion by 2018, with a compound annual growth rate (CAGR) of 9.6% between 2013 and 2018. This report provides: An overview of the global market for services and devices in the bariatric surgery ...  |  read more...
USD 6,650
Physician Views: What opportunity for Novo Nordisk's Victoza in obesity?
11/1/2013 | published by: FirstWord
... approval of Victoza (its GLP-1 anti-diabetic) for the treatment of obesity. Most recent Phase III data – published in May – supports a consensus view that Victoza will be filed for obesity and stands a ...  |  read more...
USD 645
PharmaPoint: Obesity - Japan Drug Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. ...  |  read more...
USD 4,995
Velneperit (Obesity) - Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this ...  |  read more...
USD 3,495
PharmaPoint: Obesity - Canada Drug Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. ...  |  read more...
USD 4,995
PharmaPoint: Obesity - Current and Future Players
10/31/2013 | published by: GlobalData
... the companies in the rapidly growing obesity market. The report identifies and analyses the key companies shaping and driving the global obesity market. The report provides insight into the competitive obesity landscape, including new companies ...  |  read more...
USD 2,995
Belviq (Obesity) - Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this ...  |  read more...
USD 3,495
Victoza (Obesity) - Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this ...  |  read more...
USD 3,495
Contrave (Obesity) - Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this ...  |  read more...
USD 3,495
PharmaPoint: Obesity - Spain Drug Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. ...  |  read more...
USD 4,995
PharmaPoint: Obesity - Germany Drug Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... will lend considerable visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. ...  |  read more...
USD 4,995
Empatic (Obesity) - Forecast and Market Analysis to 2022
10/31/2013 | published by: GlobalData
... visibility to this indication space. This includes the use of combination therapies that simultaneously target multiple pathways and regulate appetite control, as well as novel molecular entities with new mechanisms of action. Due to this ...  |  read more...
USD 3,495
< prev 1    3  4  5  6  
 
Our Clients